
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pathological features, clinical presentations and prognostic factors of ovarian large cell neuroendocrine carcinoma: a case report and review of published literature
Xiaohang Yang, Junyu Chen, Ruiying Dong
Journal of Ovarian Research (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Xiaohang Yang, Junyu Chen, Ruiying Dong
Journal of Ovarian Research (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Neuroendocrine tumors of the gynecologic tract update
Ira Winer, C. Kim, P.A. Gehrig
Gynecologic Oncology (2021) Vol. 162, Iss. 1, pp. 210-219
Closed Access | Times Cited: 44
Ira Winer, C. Kim, P.A. Gehrig
Gynecologic Oncology (2021) Vol. 162, Iss. 1, pp. 210-219
Closed Access | Times Cited: 44
Neuroendocrine Neoplasms of the Gynecologic Tract
Mayur Virarkar, Sai Swarupa Vulasala, Ajaykumar C. Morani, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1835-1835
Open Access | Times Cited: 30
Mayur Virarkar, Sai Swarupa Vulasala, Ajaykumar C. Morani, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1835-1835
Open Access | Times Cited: 30
Primary ovarian neuroendocrine neoplasia with concurrent large epithelial borderline ovarian tumor, coexistent with non-malignant pleural effusion and multiple uterine fibroids: a case report and review of the literature
Mariam M. Mohsin, Rajani Dube, Dina Hamza, et al.
Journal of Medical Case Reports (2025) Vol. 19, Iss. 1
Open Access
Mariam M. Mohsin, Rajani Dube, Dina Hamza, et al.
Journal of Medical Case Reports (2025) Vol. 19, Iss. 1
Open Access
Trastuzumab deruxtecan effectively controlled recurrent ovarian large-cell neuroendocrine carcinoma with low-level HER-2 expression: a case report
Yurou Xing, Yidan Cao, Xin Wu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Yurou Xing, Yidan Cao, Xin Wu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary
Ying Zhu, Fan-long Meng, Huibin Fang, et al.
International Journal of Gynecological Cancer (2019) Vol. 30, Iss. 2, pp. 207-212
Closed Access | Times Cited: 24
Ying Zhu, Fan-long Meng, Huibin Fang, et al.
International Journal of Gynecological Cancer (2019) Vol. 30, Iss. 2, pp. 207-212
Closed Access | Times Cited: 24
INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas
Qiong Zou, Lily Zhang, Zhiqiang Cheng, et al.
The American Journal of Surgical Pathology (2020) Vol. 45, Iss. 2, pp. 147-159
Closed Access | Times Cited: 22
Qiong Zou, Lily Zhang, Zhiqiang Cheng, et al.
The American Journal of Surgical Pathology (2020) Vol. 45, Iss. 2, pp. 147-159
Closed Access | Times Cited: 22
Primary neuroendocrine tumors of the ovary: Management and outcomes
Li Pang, Zhiqiang Guo
Cancer Medicine (2021) Vol. 10, Iss. 23, pp. 8558-8569
Open Access | Times Cited: 19
Li Pang, Zhiqiang Guo
Cancer Medicine (2021) Vol. 10, Iss. 23, pp. 8558-8569
Open Access | Times Cited: 19
First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial
Sonja Levy, Wieke H.M. Verbeek, Ferry A.L.M. Eskens, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 9
Sonja Levy, Wieke H.M. Verbeek, Ferry A.L.M. Eskens, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 9
Large-cell neuroendocrine carcinoma of the gynecologic tract: Prevalence, survival outcomes, and associated factors
Li Pang, Jie Chen, Xiaohan Chang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Li Pang, Jie Chen, Xiaohan Chang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Neuroendocrine neoplasms of the ovary: an analysis of clinicopathological characteristics and prognosis with a focus on histological grading
Wu Huang, Yiting Bao, Xukai Luo, et al.
Endocrine (2022) Vol. 77, Iss. 1, pp. 188-198
Closed Access | Times Cited: 8
Wu Huang, Yiting Bao, Xukai Luo, et al.
Endocrine (2022) Vol. 77, Iss. 1, pp. 188-198
Closed Access | Times Cited: 8
Pure large-cell neuroendocrine carcinoma of the ovary with a somatic BRCA1 mutation: The first reported case and the review of the literature
Musen Wang, Fei Gao, Xiao Wang, et al.
SAGE Open Medical Case Reports (2024) Vol. 12
Open Access | Times Cited: 1
Musen Wang, Fei Gao, Xiao Wang, et al.
SAGE Open Medical Case Reports (2024) Vol. 12
Open Access | Times Cited: 1
The puzzle of gynecologic neuroendocrine carcinomas: State of the art and future directions
Giuseppe Caruso, María Carolina Cabrera Schulmeyer, Federica Tomao, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 162, pp. 103344-103344
Closed Access | Times Cited: 9
Giuseppe Caruso, María Carolina Cabrera Schulmeyer, Federica Tomao, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 162, pp. 103344-103344
Closed Access | Times Cited: 9
Primary pure large cell neuroendocrine carcinoma of the ovary: histopathologic and immunohistochemical analysis with review of the literature.
Parikshaa Gupta, Rashmi Bagga, Bhavana Rai, et al.
International Journal of Clinical and Experimental Pathology (2021) Vol. 14, Iss. 9, pp. 1000-1009
Closed Access | Times Cited: 7
Parikshaa Gupta, Rashmi Bagga, Bhavana Rai, et al.
International Journal of Clinical and Experimental Pathology (2021) Vol. 14, Iss. 9, pp. 1000-1009
Closed Access | Times Cited: 7
Differences in Characteristics and Outcomes Between Large-Cell Neuroendocrine Carcinoma of the Ovary and High-Grade Serous Ovarian Cancer: A Retrospective Observational Cohort Study
Li Pang, Zhiqiang Guo
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Li Pang, Zhiqiang Guo
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
An Ovarian Large-Cell Neuroendocrine Carcinoma Accompanied by Clear Cell Carcinoma with Specific High Level of AFP: Case Report and Review of the Literature
Jian Qiu, Jiewei Xu, Guorong Yao, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 2235-2241
Open Access | Times Cited: 4
Jian Qiu, Jiewei Xu, Guorong Yao, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 2235-2241
Open Access | Times Cited: 4
Primary pure large cell neuroendocrine carcinoma of the ovary
Xue Peng, Hongjing Wang
Medicine (2020) Vol. 99, Iss. 49, pp. e22474-e22474
Open Access | Times Cited: 4
Xue Peng, Hongjing Wang
Medicine (2020) Vol. 99, Iss. 49, pp. e22474-e22474
Open Access | Times Cited: 4
Neuroendocrine tumor of the fallopian tube and serous adenocarcinoma of the ovary: multicentric primary tumors
Nataliia Hyriavenko, Mykola Lуndіn, Vladyslav Sikora, et al.
Turkish Journal of Pathology (2022)
Open Access | Times Cited: 3
Nataliia Hyriavenko, Mykola Lуndіn, Vladyslav Sikora, et al.
Turkish Journal of Pathology (2022)
Open Access | Times Cited: 3
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma
Tianming Zhang, Zhiqing Mao, Ming-Hui Ma, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 916-934
Open Access
Tianming Zhang, Zhiqing Mao, Ming-Hui Ma, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 916-934
Open Access
Clinicopathologic feature and treatment progress of high-grade ovarian neuroendocrine tumors
Qionghua He, Chenyan Wang, Da Wei Huang, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access
Qionghua He, Chenyan Wang, Da Wei Huang, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access
Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases
Michaela Bártů, Kristýna Němejcová, Romana Michálková, et al.
International Journal of Gynecological Pathology (2023)
Closed Access | Times Cited: 1
Michaela Bártů, Kristýna Němejcová, Romana Michálková, et al.
International Journal of Gynecological Pathology (2023)
Closed Access | Times Cited: 1
Contemporary principles of diagnostic and therapeutic management in cervical and ovarian neuroendocrine tumors
Mariusz Bidziński, Szymon Piątek, Jarosław B. Ćwikła, et al.
Ginekologia Polska (2021)
Open Access | Times Cited: 3
Mariusz Bidziński, Szymon Piątek, Jarosław B. Ćwikła, et al.
Ginekologia Polska (2021)
Open Access | Times Cited: 3
Clinical and histological features of primary pure large-cell neuroendocrine carcinoma of the ovary
Sana Ennouri, J. Feki, Syrine Sghaier, et al.
Libyan Journal of Medical Sciences (2020) Vol. 4, Iss. 2, pp. 90-90
Closed Access | Times Cited: 1
Sana Ennouri, J. Feki, Syrine Sghaier, et al.
Libyan Journal of Medical Sciences (2020) Vol. 4, Iss. 2, pp. 90-90
Closed Access | Times Cited: 1
Primary Pure Large-Cell Neuroendocrine Carcinoma of the Ovary
Reena Yadav, Kanika Chopra, Nishtha Jaiswal, et al.
Gynecology and Minimally Invasive Therapy (2022) Vol. 11, Iss. 3, pp. 176-178
Open Access | Times Cited: 1
Reena Yadav, Kanika Chopra, Nishtha Jaiswal, et al.
Gynecology and Minimally Invasive Therapy (2022) Vol. 11, Iss. 3, pp. 176-178
Open Access | Times Cited: 1
Pure large cell neuroendocrine carcinoma of the ovary with a somatic BRCA1 mutation: the first reported case and the review of the literature
Musen Wang, Fei Gao, Xiao Wang, et al.
Research Square (Research Square) (2023)
Open Access
Musen Wang, Fei Gao, Xiao Wang, et al.
Research Square (Research Square) (2023)
Open Access
Undifferentiated, Mixed and Other Tumours of the Ovary
David B. Chapel
Springer eBooks (2023), pp. 479-514
Closed Access
David B. Chapel
Springer eBooks (2023), pp. 479-514
Closed Access